For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer Atlantis Japan Growth Fund
of existing shares to which voting rights are Limited
attached:
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights yes
An acquisition or disposal of qualifying financial instruments which may
result in the acquisition of shares already issued to which voting rights
are attached
An acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the 1607 Capital Partners, LLC
notification obligation:
Northern Trust 2,142,702
4. Full name of shareholder(s)
(if different from 3.): Bny Mellon 1,650,951
State Street 619,142
5. Date of the transaction and date on
which the threshold is crossed or September 3, 2014
reached:
6. Date on which issuer notified: September 4, 2014
7. Threshold(s) that is/are crossed or 10%
reached:
8. Notified details:
A: Voting rights attached to shares
Class/type Situation previous Resulting situation after the triggering transaction
of to the triggering
shares transaction
Number Number Number Number of voting % of voting rights x
if possible of of of rights
using Shares Voting shares
the ISIN Rights
CODE Direct Direct xi Indirect Direct Indirect
xii
GB000623560 4,212,795 4,212,795 4,412,795 10.09%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion Period rights that may be rights
instrument acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
Resulting situation after the triggering transaction
Type of Exercise price Expiration Exercise/ Number of voting rights % of voting rights
financial date Conversion instrument refers to
instrument period
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
Same as A
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
15. Contact telephone number:
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification
obligation
Full name
1607 Capital Partners,
(including legal form of legal entities) LLC
Contact address 4991 Lake Brook Dr.,
Suite 125
(registered office for legal entities)
Glen Allen, VA, USA
23060
Phone number & email 804-525-1741
bhuntley@1607capital.com
Other useful information
(at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name Bryan Huntley
Contact address Same as above
Phone number & email Same as above
Other useful information Chief Compliance Officer
(e.g. functional relationship with the person or legal entity
subject to the notification obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.
END
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.